10 Analysts Have This to Say About Kohl’s
Within the last quarter, Kohl's (NYSE:KSS) has observed the following analyst ratings:
Deutsche Bank Maintains Buy on Kohl’s, Lowers Price Target to $36
Deutsche Bank analyst Gabriella Carbone maintains Kohl's (NYSE:KSS) with a Buy and lowers the price target from $37 to $36.
Kohl’s Has ‘Competitive Advantages’ Via Full-Family Offering, Says This Analyst
Telsey Advisory Group analyst Dana Telsey reiterated a Market Perform rating on Kohl’s Corp (NYSE:KSS) with a price target of $35.00. The analyst…
Kohl’s, Sephora Announce Planned Expansion Of Sephora Presence To All Kohl’s Stores
As Sephora at Kohl's celebrates one year since first opening its doors, Kohl's (NYSE:KSS) and Sephora announce plans that the companies' transformative partnership will expand to include a Sephora presence at
Kohl’s Shares Are Sliding During Thursday’s Pre-Market: Here’s Why
Shares of Kohl’s Corporation (NYSE: KSS) are sliding on Thursday due to a worse-than-expected earnings report along with a cut to its full year financial outlook.
Why Is It Moving?
Kohl’s Shares Drop As Inflation Affects Q2 Earnings; Cuts FY22 Outlook Sharply
Kohl’s Corp (NYSE:KSS) reported a second-quarter FY22 revenue decline of 8.1% year-on-year to $4.09 billion, beating the consensus of $3.85 billion.…
Kohl’s Q2 EPS $1.11 Misses $1.14 Estimate, Sales $4.09B Beat $3.85B Estimate
Kohl's (NYSE:KSS) reported quarterly earnings of $1.11 per share which missed the analyst consensus estimate of $1.14 by 2.63 percent. This is a 55.24 percent decrease over earnings of $2.48 per share from the same
Earnings Scheduled For August 18, 2022
Companies Reporting Before The Bell
• Calliditas Therapeutics (NASDAQ:CALT) is expected to report quarterly loss at $1.00 per share on revenue of $7.50 million.